Malignant pleural disease

被引:55
作者
Bonomo, L [1 ]
Feragalli, B [1 ]
Sacco, R [1 ]
Merlino, B [1 ]
Storto, ML [1 ]
机构
[1] Univ Chieti, Dept Radiol, SS Annunziata Hosp, I-66013 Chieti, Italy
关键词
malignant pleural mesothelioma; CT; MR; pleural neoplasms;
D O I
10.1016/S0720-048X(00)00168-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The vast majority of pleural neoplasms invade the pleura secondarily and can be seen in patients with bronchogenic carcinoma breast cancer. lymphoma. and ovarian or gastric carcinoma, Primary pleural neoplasms are less common. although they have developed notoriety since the up-surge of malignant mesothelioma and the knowledge of its connection to asbestos exposure. Other malignant primary tumors include localized fibrous tumor and pleural liposarcoma. In most patients with diffuse malignant pleural disease the chest radiograph shows pleural effusion with or without pleural thickening. Computed tomography (CT) usually provides precise localization and and extent of disease and may be of value in assessing chest wall and mediastinal involvement. In specific situations. magnetic resonance (MR) may be useful as a problem-solving tool when CT findings of chest wall or diaphragmatic invasion are equivocal or in patients with contraindication to intravenous administration of ionic contrast material. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:98 / 118
页数:21
相关论文
共 94 条
  • [1] ABERLE DR, 1991, CLIN CHEST MED, V12, P115
  • [2] AISNER J, 1995, CHEST, V108, P1122
  • [3] MALIGNANT MESOTHELIOMA
    ANTMAN, KH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (04) : 200 - 202
  • [4] Malignant pleural mesothelioma
    Baas, P
    Schouwink, H
    Zoetmulder, FAN
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (02) : 139 - 149
  • [5] MR EVALUATION OF CHEST-WALL INVOLVEMENT IN MALIGNANT-LYMPHOMA
    BERGIN, CJ
    HEALY, MV
    ZINCONE, GE
    CASTELLINO, RA
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1990, 14 (06) : 928 - 932
  • [6] BOUTIN C, 1993, CANCER, V72, P389, DOI 10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO
  • [7] 2-V
  • [8] BOUTIN C, 1993, CANCER, V72, P394, DOI 10.1002/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO
  • [9] 2-5
  • [10] BRISELLI M, 1981, CANCER, V47, P2678, DOI 10.1002/1097-0142(19810601)47:11<2678::AID-CNCR2820471126>3.0.CO